Roivant Sciences Ltd. (ROIV)
USD 9.03
(-2.54%)
USD 9.03
(-2.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 4.34 Billion USD | 453.56% |
| 2023 | 4.34 Billion USD | -33.1% |
| 2022 | -1 Billion USD | -2.65% |
| 2021 | -845.26 Million USD | -174.99% |
| 2020 | -809.23 Million USD | 215.22% |
| 2019 | 1.2 Billion USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 4.34 Billion USD | 453.56% |
| 2024 Q1 | -291.81 Million USD | 163.06% |
| 2024 Q2 | -304.32 Million USD | -341.54% |
| 2024 Q3 | 5.09 Billion USD | 1774.58% |
| 2024 Q4 | -151.11 Million USD | -102.97% |
| 2023 Q1 | -353.78 Million USD | -21.44% |
| 2023 FY | -1.23 Billion USD | -33.1% |
| 2023 Q4 | -175.42 Million USD | 54.42% |
| 2023 Q3 | -384.89 Million USD | -21.83% |
| 2023 Q2 | -315.92 Million USD | 10.7% |
| 2022 Q4 | -291.31 Million USD | -2.38% |
| 2022 FY | -924.11 Million USD | -2.65% |
| 2022 Q3 | -284.53 Million USD | -36.48% |
| 2022 Q2 | -208.48 Million USD | -153.68% |
| 2022 Q1 | -82.18 Million USD | 83.87% |
| 2021 Q1 | -3.24 Million USD | 94.6% |
| 2021 Q2 | -35.39 Million USD | -991.52% |
| 2021 Q4 | -509.56 Million USD | -95.21% |
| 2021 Q3 | -261.02 Million USD | -637.41% |
| 2021 FY | -900.23 Million USD | -174.99% |
| 2020 Q4 | -60.01 Million USD | 0.0% |
| 2020 FY | 1.2 Billion USD | 215.22% |
| 2019 FY | -1.04 Billion USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 1087.849% |
| AlloVir, Inc. | -190.41 Million USD | 2383.884% |
| Aptorum Group Limited | -2.82 Million USD | 154063.522% |
| Ardelyx, Inc. | -66.06 Million USD | 6682.599% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 2218.585% |
| Bicycle Therapeutics plc | -180.66 Million USD | 2507.19% |
| AbCellera Biologics Inc. | -146.39 Million USD | 3070.618% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 2528.848% |
| Chimerix, Inc. | -82.09 Million USD | 5397.431% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | 9850.23% |
| Elevation Oncology, Inc. | -45.7 Million USD | 9615.417% |
| Alkermes plc | 355.75 Million USD | -1122.443% |
| Fortress Biotech, Inc. | -60.63 Million USD | 7272.067% |
| Fortress Biotech, Inc. | -60.63 Million USD | 7272.067% |
| Agenus Inc. | -245.76 Million USD | 1869.575% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | 5430.873% |
| Dyadic International, Inc. | -6.79 Million USD | 64097.512% |
| ImmuCell Corporation | -5.77 Million USD | 75411.32% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | 464728.846% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | 3949.936% |
| Lantern Pharma Inc. | -15.96 Million USD | 27346.291% |
| Immix Biopharma, Inc. | -15.42 Million USD | 28292.094% |
| Incyte Corporation | 597.59 Million USD | -627.733% |
| IO Biotech, Inc. | -86.08 Million USD | 5152.015% |
| Janux Therapeutics, Inc. | -58.29 Million USD | 7560.46% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | 22954.342% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | 7473.227% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 2742.535% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 2942.584% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 51257.817% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | 8091.118% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | -8238.624% |
| ContextLogic Inc. | -317 Million USD | 1471.901% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | 6029.249% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 1263.966% |
| MiMedx Group, Inc. | 67.43 Million USD | -6348.681% |
| MEI Pharma, Inc. | 17.77 Million USD | -24362.403% |
| Novavax, Inc. | -545.06 Million USD | 897.877% |
| NextCure, Inc. | -62.72 Million USD | 7033.543% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | 43650.23% |
| Onconetix, Inc. | -37.4 Million USD | 11725.131% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | 11115.796% |
| Opthea Limited | -220.24 Million USD | 2074.612% |
| Psyence Biomedical Ltd. | -51.15 Million USD | 8600.795% |
| Vaxcyte, Inc. | -402.26 Million USD | 1181.107% |
| PDS Biotechnology Corporation | -42.94 Million USD | 10227.395% |
| Precigen, Inc. | -95.9 Million USD | 4634.666% |
| Pharming Group N.V. | -10.54 Million USD | 41329.863% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 2257.291% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | 17819.619% |
| PureTech Health plc | -65.69 Million USD | 6719.672% |
| Pyxis Oncology, Inc. | -73.79 Million USD | 5993.652% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | 17432.613% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 2149.254% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | 23549.281% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 17967.923% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 17967.923% |
| Seer, Inc. | -86.27 Million USD | 5140.655% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 1786.735% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | 16066.393% |
| Acelyrin, Inc. | -381.64 Million USD | 1239.533% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | 34673092.795% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | 11746.829% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | 12853.075% |
| Senti Biosciences, Inc. | -92.91 Million USD | 4780.341% |
| Clearside Biomedical, Inc. | -32.48 Million USD | 13487.49% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | 4253.742% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | 12475.999% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | 33369.364% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | 65154.989% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | 14911.409% |
| VYNE Therapeutics Inc. | -28.45 Million USD | 15385.133% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 21532.783% |
| Wave Life Sciences Ltd. | -57.51 Million USD | 7661.64% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | 7085.665% |
| C4 Therapeutics, Inc. | -132.49 Million USD | 3382.382% |
| ChromaDex Corporation | -4.93 Million USD | 88170.595% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 859.183% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | 121307.525% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 8617.619% |
| Caribou Biosciences, Inc. | -102.07 Million USD | 4360.729% |
| CRISPR Therapeutics AG | -153.61 Million USD | 2931.148% |
| Precision BioSciences, Inc. | -61.31 Million USD | 7192.298% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 2802.405% |
| Innoviva, Inc. | 179.72 Million USD | -2319.807% |
| Jaguar Health, Inc. | -41.3 Million USD | 10630.087% |
| Summit Therapeutics Inc. | -614.92 Million USD | 807.225% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | 6591.419% |
| Aadi Bioscience, Inc. | -65.76 Million USD | 6712.827% |
| ESSA Pharma Inc. | -26.58 Million USD | 16460.206% |
| GlycoMimetics, Inc. | -36.89 Million USD | 11885.893% |
| GT Biopharma, Inc. | -7.59 Million USD | 57345.307% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 1901.835% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | 8475.399% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | -5990.08% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | 8953.677% |
| Alzamend Neuro, Inc. | -9.94 Million USD | 43817.702% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 1870.771% |
| Aptose Biosciences Inc. | -51.2 Million USD | 8592.835% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | 4524.229% |
| Soligenix, Inc. | -6.14 Million USD | 70920.994% |
| Century Therapeutics, Inc. | -136.67 Million USD | 3281.994% |
| Kura Oncology, Inc. | -152.63 Million USD | 2949.307% |
| TScan Therapeutics, Inc. | -89.21 Million USD | 4974.494% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | 41368.988% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | -768981.649% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | 764410.369% |
| Autolus Therapeutics plc | -208.38 Million USD | 2186.987% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | 6148.744% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | 6242.985% |
| Eterna Therapeutics Inc. | -21.66 Million USD | 20170.731% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 2030.711% |
| GRI Bio, Inc. | -13.03 Million USD | 33458.334% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | 105284.278% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | 3604.824% |
| IGM Biosciences, Inc. | -246.41 Million USD | 1864.872% |
| INmune Bio, Inc. | -30 Million USD | 14592.555% |
| Heron Therapeutics, Inc. | -110.55 Million USD | 4033.579% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 10407.03% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 27346.079% |
| Entero Therapeutics, Inc. | -15.79 Million USD | 27633.591% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | 7386.464% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | 4398.759% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 1674.979% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 1928.109% |
| Verastem, Inc. | -87.36 Million USD | 5077.767% |
| Abeona Therapeutics Inc. | -54.18 Million USD | 8125.626% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 2795.571% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | 3827.928% |
| Histogen Inc. | -10.62 Million USD | 41046.483% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | 30540.262% |
| Surrozen, Inc. | -43.04 Million USD | 10203.912% |
| Organovo Holdings, Inc. | -14.67 Million USD | 29743.01% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 85590.49% |
| Ovid Therapeutics Inc. | -52.33 Million USD | 8409.156% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | 17314.606% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | 16244.205% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | 52138.785% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 2978.463% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | 8988.775% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | 14730.533% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | 41845.532% |
| Apollomics, Inc. | -172.6 Million USD | 2619.641% |
| Amarin Corporation plc | -59.11 Million USD | 7457.095% |
| Mesoblast Limited | -87.95 Million USD | 5044.434% |
| Turnstone Biologics Corp. | -55.2 Million USD | 7978.489% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 3059.218% |
| Synaptogenix, Inc. | -6.03 Million USD | 72119.924% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | 26931.972% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | 5674.117% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 90863.996% |
| Monopar Therapeutics Inc. | -8.4 Million USD | 51859.397% |
| Exelixis, Inc. | 207.76 Million USD | -1993.195% |
| Better Therapeutics, Inc. | -39.76 Million USD | 11037.943% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 3121.178% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 922.682% |
| NLS Pharmaceutics AG | -12.17 Million USD | 35828.85% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | 55893.444% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | 14243.309% |
| Gritstone bio, Inc. | -138.49 Million USD | 3240.246% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 6846.182% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 108824.509% |
| Avid Bioservices, Inc. | -140.75 Million USD | 3189.757% |
| Insmed Incorporated | -749.56 Million USD | 680.192% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | 28731.118% |
| MediWound Ltd. | -6.71 Million USD | 64854.705% |
| OmniAb, Inc. | -50.61 Million USD | 8691.489% |
| Alector, Inc. | -130.39 Million USD | 3435.296% |
| Seres Therapeutics, Inc. | -113.72 Million USD | 3924.106% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | 8487.999% |
| Zai Lab Limited | -334.62 Million USD | 1399.661% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 1442.319% |
| Aura Biosciences, Inc. | -76.4 Million USD | 5791.716% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 1953.509% |
| Immunic, Inc. | -93.61 Million USD | 4745.693% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | 3300.258% |
| Veracyte, Inc. | -74.4 Million USD | 5945.016% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | 56759.471% |
| FibroGen, Inc. | -284.23 Million USD | 1630.062% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 16678.705% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 62210.744% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | 23192.426% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | -948.358% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | 19381.428% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | -8726.543% |
| TG Therapeutics, Inc. | 12.67 Million USD | -34219.176% |
| Galecto, Inc. | -38.34 Million USD | 11440.39% |
| Calithera Biosciences, Inc. | -18.86 Million USD | 23151.659% |
| Fortrea Holdings Inc. | -3.4 Million USD | 128009.588% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | 3533.977% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | 25078.037% |
| XBiotech Inc. | -24.55 Million USD | 17809.517% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 6846.182% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | 7038.299% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | 4518.473% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | 20396.476% |
| Theravance Biopharma, Inc. | -55.19 Million USD | 7979.488% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 816.889% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | 6471.586% |
| Vaxxinity, Inc. | -56.93 Thousand USD | 7638639.361% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 2019.725% |
| Gain Therapeutics, Inc. | -22.26 Million USD | 19630.356% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 2079.394% |
| NexImmune, Inc. | -32.34 Million USD | 13545.688% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | 82363.598% |
| Marker Therapeutics, Inc. | -14.04 Million USD | 31062.256% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | -9.999% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | 18055.188% |
| Scopus BioPharma Inc. | -11.6 Million USD | 37559.008% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | 3823.459% |
| Ainos, Inc. | -13.77 Million USD | 31681.355% |
| Pluri Inc. | -20.88 Million USD | 20920.213% |
| Prothena Corporation plc | -147.02 Million USD | 3057.89% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | 3919.169% |
| Celularity Inc. | -196.29 Million USD | 2315.505% |
| Rallybio Corporation | -74.56 Million USD | 5932.474% |
| Cue Biopharma, Inc. | -50.73 Million USD | 8672.184% |
| MeiraGTx Holdings plc | -84.02 Million USD | 5275.629% |
| Omeros Corporation | -117.81 Million USD | 3791.38% |
| Humacyte, Inc. | -110.77 Million USD | 4025.874% |
| Immunocore Holdings plc | -55.28 Million USD | 7966.091% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | 24282.195% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | 19065.27% |
| Blueprint Medicines Corporation | -506.98 Million USD | 957.803% |
| CalciMedica, Inc. | -34.35 Million USD | 12758.049% |
| Cabaletta Bio, Inc. | -67.67 Million USD | 6526.193% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 3175.511% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 2723.169% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 1635.34% |
| Pulmatrix, Inc. | -14.12 Million USD | 30897.578% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | 12456.659% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | 5362.623% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 1003.782% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | 4246.929% |
| Cytokinetics, Incorporated | -526.24 Million USD | 926.409% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | 12158.578% |
| Nutriband Inc. | -5.48 Million USD | 79383.082% |
| Protara Therapeutics, Inc. | -40.42 Million USD | 10859.342% |
| Vor Biopharma Inc. | -117.86 Million USD | 3789.814% |
| Evogene Ltd. | -23.87 Million USD | 18312.346% |
| ProKidney Corp. | -35.46 Million USD | 12361.548% |
| Applied Therapeutics, Inc. | -119.76 Million USD | 3731.277% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | 55532.885% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 776.137% |
| CorMedix Inc. | -46.33 Million USD | 9484.977% |
| BioLineRx Ltd. | -60.61 Million USD | 7274.788% |
| Tango Therapeutics, Inc. | -101.74 Million USD | 4374.381% |
| Galectin Therapeutics Inc. | -41.06 Million USD | 10690.089% |
| Atai Life Sciences N.V. | -40.22 Million USD | 10911.769% |
| Renovaro Biosciences Inc. | -80.65 Million USD | 5492.333% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | 5858.565% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 1588.385% |
| Sagimet Biosciences Inc. | -27.87 Million USD | 15700.969% |
| MediciNova, Inc. | -8.57 Million USD | 50836.952% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | 3627.768% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 52016.106% |
| GeoVax Labs, Inc. | -25.96 Million USD | 16848.049% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 1917.824% |
| Biomea Fusion, Inc. | -117.25 Million USD | 3808.947% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 794.047% |
| Mereo BioPharma Group plc | -29.46 Million USD | 14859.133% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 2939.429% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 2177.248% |
| Absci Corporation | -110.56 Million USD | 4033.33% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 14524.299% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | 4412.828% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 1943.257% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | -30778.486% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 2353.773% |
| Allakos Inc. | -185.7 Million USD | 2441.897% |
| Imunon, Inc. | -19.51 Million USD | 22385.069% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | 4567.998% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | -3997.349% |
| BioAtla, Inc. | -123.46 Million USD | 3622.481% |
| NLS Pharmaceutics AG | -12.17 Million USD | 35828.85% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | 27148.924% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 1428.87% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | 11870.078% |
| XOMA Corporation | -40.83 Million USD | 10751.04% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | 4369.094% |
| Cara Therapeutics, Inc. | -118.51 Million USD | 3769.577% |
| aTyr Pharma, Inc. | -50.38 Million USD | 8730.705% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | 5060.054% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 2965.679% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 1929.324% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | 12483.399% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | 53843.923% |
| Akari Therapeutics, Plc | -10 Million USD | 43554.496% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 6459700.446% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | -1444.396% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 65351.191% |
| UroGen Pharma Ltd. | -102.24 Million USD | 4353.478% |
| Sutro Biopharma, Inc. | -106.79 Million USD | 4172.295% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | 56019.032% |
| Orgenesis Inc. | -55.36 Million USD | 7955.577% |
| Entera Bio Ltd. | -8.88 Million USD | 49024.806% |
| GH Research PLC | -35.58 Million USD | 12320.547% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | 20968.167% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | 5719.639% |
| Xencor, Inc. | -126.08 Million USD | 3549.147% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | 115587.79% |
| Replimune Group, Inc. | -215.79 Million USD | 2115.314% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | 20549.62% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | -173233.041% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 65351.191% |
| Portage Biotech Inc. | -75.33 Million USD | 5872.476% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 52016.106% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | 4599.432% |
| OncoCyte Corporation | -27.78 Million USD | 15754.318% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | 32513.038% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | 39203.702% |
| Purple Biotech Ltd. | -19.88 Million USD | 21975.885% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | 62059.339% |
| scPharmaceuticals Inc. | -54.81 Million USD | 8034.548% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | 24942.287% |
| HilleVax, Inc. | -123.56 Million USD | 3619.517% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | 43128.851% |
| Tharimmune, Inc. | -9.31 Million USD | 46766.833% |
| Genprex, Inc. | -30.86 Million USD | 14192.226% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 1943.351% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | 14551.14% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | 244147.475% |
| Virios Therapeutics, Inc. | -5.29 Million USD | 82216.95% |
| OKYO Pharma Limited | -16.82 Thousand USD | 25847393.328% |
| Savara Inc. | -54.69 Million USD | 8050.795% |
| Curis, Inc. | -47.41 Million USD | 9272.434% |
| Daré Bioscience, Inc. | -30.16 Million USD | 14518.851% |
| Carmell Therapeutics Corporation | -15.44 Million USD | 28257.342% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | 78191.686% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | 14686.369% |
| BeiGene, Ltd. | -881.7 Million USD | 593.239% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | 20523.246% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 1096.621% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | 5608.107% |
| Erasca, Inc. | -125.04 Million USD | 3577.972% |
| bluebird bio, Inc. | -211.91 Million USD | 2152.222% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 87069.875% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | -2494.128% |
| DBV Technologies S.A. | -72.72 Million USD | 6079.878% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 87069.875% |
| Moderna, Inc. | -4.71 Billion USD | 192.256% |
| Vincerx Pharma, Inc. | -40.15 Million USD | 10929.808% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | 76477.345% |
| Molecular Templates, Inc. | -8.12 Million USD | 53631.832% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | 7301.639% |
| Travere Therapeutics, Inc. | -111.39 Million USD | 4003.918% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | 3313.049% |
| Spruce Biosciences, Inc. | -47.91 Million USD | 9175.578% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 3174.989% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 2360.239% |
| MacroGenics, Inc. | -9.05 Million USD | 48111.989% |
| RenovoRx, Inc. | -10.23 Million USD | 42603.186% |
| Adicet Bio, Inc. | -142.65 Million USD | 3148.498% |
| Prime Medicine, Inc. | -198.13 Million USD | 2294.953% |
| Aditxt, Inc. | -32.38 Million USD | 13530.554% |
| Adagene Inc. | -18.94 Million USD | 23053.875% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 59578.812% |
| Quantum-Si incorporated | -95.96 Million USD | 4632.02% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | 3753.669% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 29932.592% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | -3186.425% |
| SciSparc Ltd. | -5.12 Million USD | 85006.794% |
| Vericel Corporation | -3.18 Million USD | 136772.722% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 3616550.18% |
| Minerva Neurosciences, Inc. | -30 Million USD | 14593.834% |
| Generation Bio Co. | -126.61 Million USD | 3534.845% |
| Astria Therapeutics, Inc. | -72.89 Million USD | 6066.342% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | 5375.134% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 1759.009% |
| Invivyd, Inc. | -198.64 Million USD | 2289.318% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 1371.716% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | 50164.922% |
| Spero Therapeutics, Inc. | 22.8 Million USD | -18969.219% |
| Artelo Biosciences, Inc. | -9.87 Million USD | 44144.217% |
| 2seventy bio, Inc. | -217.57 Million USD | 2098.863% |
| ADMA Biologics, Inc. | -28.23 Million USD | 15500.425% |
| Clene Inc. | -49.5 Million USD | 8884.999% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | 19612.811% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | 8897.439% |
| GeoVax Labs, Inc. | -25.96 Million USD | 16848.049% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 1425.625% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | 13463.666% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | -19041.4% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | 4502.115% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 5917.65% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 2804.472% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 807.072% |
| Evaxion Biotech A/S | -22.12 Million USD | 19756.163% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | 5486.601% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 2273.724% |
| Trevena, Inc. | -40.28 Million USD | 10894.326% |
| Surrozen, Inc. | -43.04 Million USD | 10203.912% |
| Tyra Biosciences, Inc. | -69.13 Million USD | 6390.575% |
| Cingulate Inc. | -23.53 Million USD | 18578.588% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | 63018.49% |
| Unity Biotechnology, Inc. | -39.86 Million USD | 11010.502% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | 56501.38% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | 4920.891% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | 7196.117% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | 7408.751% |
| Clearmind Medicine Inc. | -11.95 Million USD | 36477.371% |
| Kronos Bio, Inc. | -112.67 Million USD | 3959.777% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | 6384.848% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 171472166.808% |
| Viking Therapeutics, Inc. | -85.89 Million USD | 5163.072% |
| Statera Biopharma, Inc. | -174.4 Million USD | 2593.534% |
| ImmunityBio, Inc. | -583.19 Million USD | 845.706% |
| Korro Bio, Inc. | -81.17 Million USD | 5457.668% |
| Kineta, Inc. | -14.09 Million USD | 30945.634% |
| BioVie Inc. | -32.12 Million USD | 13639.396% |
| Codexis, Inc. | -76.24 Million USD | 5804.258% |
| Celularity Inc. | -196.29 Million USD | 2315.505% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 2127.197% |
| Celcuity Inc. | -63.77 Million USD | 6918.73% |
| Virax Biolabs Group Limited | -6.73 Million USD | 64686.056% |
| Cibus, Inc. | -267.62 Million USD | 1724.995% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | 10884.422% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | 12244.107% |
| IN8bio, Inc. | -30 Million USD | 14593.038% |
| Kodiak Sciences Inc. | -260.49 Million USD | 1769.511% |
| Annexon, Inc. | -134.23 Million USD | 3339.737% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | 3811.796% |
| Assembly Biosciences, Inc. | -61.22 Million USD | 7202.839% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | 13886.856% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 1287.303% |
| Eyenovia, Inc. | -27.26 Million USD | 16052.866% |
| Puma Biotechnology, Inc. | 21.59 Million USD | -20042.309% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 812983.364% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | 5792.014% |
| Arcellx, Inc. | -70.69 Million USD | 6252.109% |
| Cardiff Oncology, Inc. | -41.44 Million USD | 10594.259% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | 3349.93% |
| Regulus Therapeutics Inc. | -30.03 Million USD | 14578.563% |
| Moolec Science SA | -51.78 Million USD | 8497.413% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | 8404.073% |
| Geron Corporation | -184.12 Million USD | 2461.917% |
| LAVA Therapeutics N.V. | -41.97 Million USD | 10461.0% |
| Royalty Pharma plc | 1.13 Billion USD | -283.221% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | 3298.775% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | 49009.383% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | 20572.055% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 2633.306% |
| Humacyte, Inc. | -110.77 Million USD | 4025.874% |
| Structure Therapeutics Inc. | -89.62 Million USD | 4952.629% |
| 89bio, Inc. | -142.18 Million USD | 3158.553% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | 6406.447% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | 42009.28% |
| Genelux Corporation | -28.29 Million USD | 15468.859% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | 15062.759% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 2555.37% |
| Notable Labs, Ltd. | -11.26 Million USD | 38709.073% |
| Liquidia Corporation | -78.5 Million USD | 5639.892% |
| Mustang Bio, Inc. | -51.6 Million USD | 8527.825% |
| Immunovant, Inc. | -259.33 Million USD | 1776.947% |
| Quantum-Si incorporated | -95.96 Million USD | 4632.02% |
| Arbutus Biopharma Corporation | -72.84 Million USD | 6069.781% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | 22539.121% |
| Vera Therapeutics, Inc. | -95.99 Million USD | 4630.603% |
| Acasti Pharma Inc. | -12.85 Million USD | 33935.883% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | 19464.829% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 27346.079% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 2484.371% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | 101202.146% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | 34975.108% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | 14846.621% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | 11254.524% |
| PepGen Inc. | -78.62 Million USD | 5631.155% |
| Moleculin Biotech, Inc. | -29.76 Million USD | 14708.909% |
| United Therapeutics Corporation | 984.8 Million USD | -341.605% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | 19636.954% |
| Solid Biosciences Inc. | -96.01 Million USD | 4629.424% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 90863.996% |
| Immuneering Corporation | -53.47 Million USD | 8233.148% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 85590.49% |
| Silo Pharma, Inc. | -3.7 Million USD | 117616.848% |
| Belite Bio, Inc | -31.63 Million USD | 13848.502% |
| XOMA Corporation | -40.83 Million USD | 10751.04% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | 8099.496% |
| Bionomics Limited | -15.49 Billion USD | 128.072% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 5278.218% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 15015.547% |
| uniQure N.V. | -308.47 Million USD | 1509.801% |
| Cassava Sciences, Inc. | -97.21 Million USD | 4573.421% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 59578.812% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | 3623.395% |
| Forte Biosciences, Inc. | -31.47 Million USD | 13916.641% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | 53124.671% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | 15061.215% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 812983.364% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 16678.705% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | 26481.11% |
| Altimmune, Inc. | -88.44 Million USD | 5016.985% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 2968.987% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 15015.547% |
| Compugen Ltd. | -18.75 Million USD | 23289.325% |
| Peak Bio, Inc. | -1259.26 USD | 345355785.085% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | 9544.127% |
| Benitec Biopharma Inc. | -21.75 Million USD | 20094.143% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 1383.664% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | 5342.575% |
| Zura Bio Limited | -60.36 Million USD | 7304.98% |
| PolyPid Ltd. | -23.86 Million USD | 18323.03% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | 27743.822% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | 5342.575% |
| Instil Bio, Inc. | -156.08 Million USD | 2886.219% |
| argenx SE | -295.05 Million USD | 1573.947% |
| Immunome, Inc. | -106.8 Million USD | 4171.799% |
| Compass Therapeutics, Inc. | -42.49 Million USD | 10334.212% |
| Verona Pharma plc | -54.36 Million USD | 8098.907% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | 4452.539% |
| Shattuck Labs, Inc. | -87.29 Million USD | 5081.702% |
| CervoMed Inc. | -2.17 Million USD | 200338.504% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | 3588.882% |
| Plus Therapeutics, Inc. | -13.31 Million USD | 32759.402% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | 10084.906% |
| Moolec Science SA | -51.78 Million USD | 8497.413% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | 25150423.305% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | 3318.629% |
| AnaptysBio, Inc. | -163.61 Million USD | 2757.959% |
| Design Therapeutics, Inc. | -66.86 Million USD | 6604.331% |
| Leap Therapeutics, Inc. | -81.41 Million USD | 5441.742% |
| NeurAxis, Inc. | -14.62 Million USD | 29832.825% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | 11580.191% |
| Lumos Pharma, Inc. | -34.03 Million USD | 12878.181% |
| Achilles Therapeutics plc | -69.66 Million USD | 6342.627% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | 4452.539% |
| 180 Life Sciences Corp. | -19.93 Million USD | 21915.408% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | -144440.696% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 171472166.808% |
| Nutriband Inc. | -5.48 Million USD | 79383.082% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | 4418.824% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | 9047.119% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | 5741.289% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | 12902.255% |
| MoonLake Immunotherapeutics | -36 Million USD | 12177.914% |
| Palisade Bio, Inc. | -12.3 Million USD | 35457.122% |
| Tourmaline Bio, Inc. | -42.12 Million USD | 10424.105% |
| Beam Therapeutics Inc. | -132.52 Million USD | 3381.54% |
| Neurogene Inc. | -36.31 Million USD | 12074.904% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 2761.277% |
| AEON Biopharma, Inc. | -52.55 Million USD | 8374.842% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | 4531.033% |
| Sesen Bio, Inc. | -19.88 Million USD | 21971.485% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | 6175.277% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | 34852.774% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 1079.406% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | 3998.075% |
| Athira Pharma, Inc. | -117.67 Million USD | 3795.804% |
| Vaccinex, Inc. | -20.25 Million USD | 21575.117% |
| HCW Biologics Inc. | -24.99 Million USD | 17499.687% |
| XOMA Corporation | -40.83 Million USD | 10751.04% |
| Nektar Therapeutics | -276.05 Million USD | 1675.378% |
| Arvinas, Inc. | -367.3 Million USD | 1284.026% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 6459700.446% |
| Merus N.V. | -154.93 Million USD | 2906.863% |
| Omega Therapeutics, Inc. | -97.42 Million USD | 4563.733% |
| Quince Therapeutics, Inc. | -31.38 Million USD | 13956.702% |
| Rezolute, Inc. | -68.45 Million USD | 6452.599% |
| Clene Inc. | -49.5 Million USD | 8884.999% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 28296.805% |
| BeyondSpring Inc. | -21.02 Million USD | 20783.563% |
| Synlogic, Inc. | -57.28 Million USD | 7692.134% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | 36642.526% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 40271.125% |
| Peak Bio, Inc. | -1259.26 USD | 345355785.085% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | 11738.102% |
| Krystal Biotech, Inc. | 10.93 Million USD | -39681.614% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 3139.103% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 1437.703% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | 94253.69% |
| MannKind Corporation | -11.93 Million USD | 36529.268% |
| Ikena Oncology, Inc. | -68.16 Million USD | 6479.905% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | 20794.39% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | 4779.636% |
| Gossamer Bio, Inc. | -179.81 Million USD | 2518.529% |
| CohBar, Inc. | -11.96 Million USD | 36455.816% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | 16964.146% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 14524.299% |
| Legend Biotech Corporation | -518.25 Million USD | 939.15% |
| Mural Oncology plc | -207.44 Million USD | 2196.403% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 3603.949% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | 23877.974% |
| Disc Medicine, Inc. | -76.42 Million USD | 5790.152% |
| Champions Oncology, Inc. | -7.27 Million USD | 59870.836% |
| REGENXBIO Inc. | -263.49 Million USD | 1750.484% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | 41077.063% |
| Anavex Life Sciences Corp. | -47.5 Million USD | 9254.67% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | 11549.515% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | 4441.849% |
| Vaxart, Inc. | -82.46 Million USD | 5373.663% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | -1302898.235% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | 11684.004% |
| Cellectis S.A. | -101.05 Million USD | 4403.353% |
| Longeveron Inc. | -21.41 Million USD | 20409.746% |
| Repare Therapeutics Inc. | -93.79 Million USD | 4736.579% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 911.402% |
| Inozyme Pharma, Inc. | -71.16 Million USD | 6210.703% |
| Revolution Medicines, Inc. | -436.36 Million USD | 1096.621% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | 66283.625% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | 14208.896% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | 6372.52% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | 6818.356% |
| Anixa Biosciences, Inc. | -9.81 Million USD | 44427.041% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | -20.149% |
| Denali Therapeutics Inc. | -145.22 Million USD | 3094.633% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 3616550.18% |
| Veru Inc. | -93.15 Million USD | 4768.599% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | 16189.852% |
| Cingulate Inc. | -23.53 Million USD | 18578.588% |
| Passage Bio, Inc. | -102.06 Million USD | 4361.063% |
| Context Therapeutics Inc. | -23.96 Million USD | 18247.587% |
| Exicure, Inc. | -16.91 Million USD | 25811.99% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 2402.03% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | 11616.063% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | 66931.246% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 2454.87% |
| Nuvalent, Inc. | -126.21 Million USD | 3545.54% |
| ABVC BioPharma, Inc. | -10.51 Million USD | 41456.678% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | 5105.728% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | 14338.233% |
| OmniAb, Inc. | -50.61 Million USD | 8691.489% |
| Anew Medical, Inc. | 1.34 Million USD | -322969.997% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | 27204.556% |
| Lipocine Inc. | -16.35 Million USD | 26695.549% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | 6650.179% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | 6929.88% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 10407.03% |
| G1 Therapeutics, Inc. | -47.96 Million USD | 9166.496% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | 22029.938% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 903.142% |
| Ocugen, Inc. | -63.07 Million USD | 6994.521% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | 4642.813% |
| Q32 Bio Inc. | -112.96 Million USD | 3949.936% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | 25396.219% |
| Alumis Inc. Common Stock | -154.99 Million USD | 2905.885% |
| Equillium, Inc. | -13.33 Million USD | 32712.868% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | 7304.264% |
| Coya Therapeutics, Inc. | -7.98 Million USD | 54544.358% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | 23169.725% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 7460.831% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 3897.293% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | 23763.82% |
| Dominari Holdings Inc. | -22.88 Million USD | 19105.882% |
| Edesa Biotech, Inc. | -8.37 Million USD | 52031.102% |
| vTv Therapeutics Inc. | -20.25 Million USD | 21576.178% |
| Bio-Techne Corporation | 168.1 Million USD | -2487.03% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 1335.182% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | -3275.107% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | 3669.609% |
| Candel Therapeutics, Inc. | -37.93 Million USD | 11562.943% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | 3960.839% |
| Nkarta, Inc. | -117.5 Million USD | 3801.182% |
| BioCardia, Inc. | -11.57 Million USD | 37684.703% |
| Iterum Therapeutics plc | -38.37 Million USD | 11433.888% |